A Clinical Evaluation of Everolimus Eluting Coronary Stents in the Treatment of Patients With ST-Segment Elevation Myocardial Infarction.EXAMINATION Study.

Trial Profile

A Clinical Evaluation of Everolimus Eluting Coronary Stents in the Treatment of Patients With ST-Segment Elevation Myocardial Infarction.EXAMINATION Study.

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Feb 2018

At a glance

  • Drugs Everolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms EXAMINATION
  • Most Recent Events

    • 07 Feb 2018 Results of a post hoc subanalysis assessing the role of ST-segment resolution on very long-term outcomes in patients with STEMI treated with pPCI , published in the American Journal of Cardiology.
    • 30 Aug 2017 Results assessing the cost-effectiveness of EES versus BMS based on the 5-year follow-up results of the EXAMINATION trial, from a Spanish health service perspective, were presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology.
    • 30 Aug 2017 Results of a sub-study evaluating impact of BMI on stent performance (n = 1421) presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top